Julie Carman
About Julie Carman
Julie Carman is a Senior Principal Scientist at Bristol-Myers Squibb and also serves as Director of Adaptive Immunity at The Janssen Pharmaceutical Companies of Johnson & Johnson.
Current Position at The Janssen Pharmaceutical Companies
Julie Carman is currently the Director, Adaptive Immunity at The Janssen Pharmaceutical Companies of Johnson & Johnson. She has been in this role since January 2020. Based in Spring House, PA, she focuses on advancing adaptive immunity research and contributing to the development of novel therapeutics. Her extensive experience in immunology and drug discovery plays a critical role in her current responsibilities.
Previous Roles at Bristol-Myers Squibb
Julie Carman held multiple roles at Bristol-Myers Squibb, including Senior Principal Scientist and Director. She worked as the Director from 2017 to 2020 in Princeton, NJ, before her current role. Prior to that, she served again as Senior Principal Scientist and spent 17 years from 1996 to 2013 as Principal Scientist. In these positions, she contributed significantly to small molecule drug discovery and translational research.
Postdoctoral Fellowship at University of Pennsylvania
From 1990 to 1996, Julie Carman completed a postdoctoral fellowship at the University of Pennsylvania. Her research focused on immunology, exploring mechanisms and responses within the immune system. This six-year period was pivotal in establishing her expertise in the field and laid a foundation for her subsequent roles in pharmaceutical research.
Educational Background in Biochemistry
Julie Carman has a robust educational background in biochemistry. She earned her Doctor of Philosophy (Ph.D.) from the University of Wisconsin-Madison, where she studied from 1985 to 1990. Prior to that, she completed her Bachelor of Science (B.S.) at the University of Maryland College Park between 1979 to 1983. Her academic training provided a solid foundation for her career in pharmacological research.